AstraZeneca
AZN
AZN
544 hedge funds and large institutions have $17.3B invested in AstraZeneca in 2018 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 151 increasing their positions, 197 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.39% more ownership
Funds ownership: 32.17% → 34.56% (+2.4%)
23% less repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 197
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
544
Holding in Top 10
3
Calls
$225M
Puts
$73.5M
Top Buyers
| 1 | +$774M | |
| 2 | +$570M | |
| 3 | +$157M | |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$102M |
| 5 |
Primecap Management
Pasadena,
California
|
+$89.4M |
Top Sellers
| 1 | -$123M | |
| 2 | -$102M | |
| 3 | -$77.3M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$65.6M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$61.8M |